To find the latest Stock Market Today threads, click here. Happy Wednesday. Stocks rose after of a key inflation report, while upbeat earnings from several technology companies helped support ...
Even at record levels, Nancy Tengler says the opportunity isn’t over. She lays out the infrastructure and cybersecurity plays she’s leaning into for the second half of 2026.
Beldex surpasses 1.5 million app installs, reflecting growing adoption of its privacy-focused Web3 ecosystem and applications ...
Mahyar Akhbari has watched every cycle since Ethereum was born in Toronto. His catalyst list for the next bull market runs through D.C., the midterms, and Wall Street’s change of heart.
Writing in his Cassandra Unchained report, Burry disclosed that he purchased March 2027 Palantir put options struck in the low-to-mid $100 range, taking advantage of implied volatility falling to ...
Riot entered the announcement with a market worth of about $7.3 billion, according to Business Insider, suggesting the headline value of the original deal exceeds the company’s pre-deal equity value.
Strategy (Nasdaq: MSTR) has launched a public tool that shows investors exactly how well its Bitcoin holdings cover the money it owes, a move toward greater transparency about the risks on its balance ...
The U.S. Securities and Exchange Commission (SEC) could introduce two major initiatives for the crypto industry on Aug. 14, Bloomberg reported.
Jazz Pharmaceuticals (JAZZ) just made a bet on a disease that many investors have never heard of. On August 10, the drugmaker agreed to buy privately held Actio Biosciences. The prize is an ...
Bank of America put something in writing about Nvidia on August 7 that investors watching the August 26 earnings date must read first.
Veteran trader Peter Brandt carries over five decades of experience and is well-known for often correctly predicting gold and Bitcoin (BTC) price swings. His main claim to fame is predicting gold's ...
View post: Jazz Pharma buys the only shot at a disease with no FDA treatment ...